In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 33 for your search:
Drug:  motexafin gadolinium
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Diagnostic, Screening
Status: Enrolling by invitation
Age: 50 to 75
Sponsor: Other
Protocol IDs: UMCU DENSE, ZONMW-200320002-UMCU, Pink Ribbon-10074, BSP-DENSE, DCS-UU-2009-4348, NCT01315015

2.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CDR0000066627, PCI-P120-9801, MSKCC-00088, UCLA-9808021, NCI-V98-1470, NCT00003563

3.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0302038, PCI-P-PCYC-0211, NCT00054795

4.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCI-P120-9501, NCI-V96-0844

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-01092, CDR0000467802, RTOG 0513, U10CA021661, NCT00305864

6.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCYC-0223, NCT00290004

7.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: NU 02H8, 1346001, NU-0228-024, PCI-P-PCYC-0213, NCT00089284

8.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: MSKCC-01051, PCI-PCYC-0206, NCI-G01-1999, NCT00022256

9.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCYC-0221, NCT00086034

10.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCYC-0215, NCT00096837

11.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCYC-0227, NCT00129844

12.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCYC-0219, NCT00134186

13.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 21 and under at diagnosis
Sponsor: NCI
Protocol IDs: NCI-2012-01829, CDR0000504107, COG-ACNS0222, ACNS0222, U10CA098543, NCT00387790

14.

Phase: Phase II
Type: Diagnostic, Supportive care, Treatment
Status: Unknown
Age: 2 to 21
Sponsor: Other
Protocol IDs: CCLG-CNS-2007-04, CNS 2007 04, EU-20746, EUDRACT-2007-001768-60, NCT00514397

15.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Unknown
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UPCC-10807, UPCC 10807, PFIZER-807184, NCT00717587

16.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PCI-P120-9401, NCI-V96-0841

17.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCLA-HSPC-970904203, COOPER-RP-97-126, LAC-USC-6G971, UCD-RW-98-01, UCLA-HSPC-970904201, UCLA-HSPC-970904202, NCI-T97-0108, NCT00003409, T97-0108

18.

Phase: Phase I
Type: Diagnostic, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCLA-HSPC-970904303, UCLA-HSPC-970904301, UCLA-HSPC-970904302, NCI-T97-0107, NCT00003410, T97-0107

19.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: PCI-97-108, CDR0000066423, NCI-T97-0109, T97-0109, NCT00003411

20.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000066941, J9840, P30CA006973, JHOC-98062407, NCI-T97-0115, T97-0115, NCT00003798

21.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NABTT-9712 CDR0000066986, P30CA006973, NABTT-9712, JHOC-NABTT-9712, NCT00006452

22.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: NCI-2012-01845, COG-A09712, U01CA097452, CDR0000067087, CCG-09712, A09712, NCT00003909

23.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01400, 99H0239, CDR0000067517, NCI-T99-0041, OSU-9976, OSU-99H0239, U01CA076576, T99-0041, NCT00004262

24.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01401, OSU 0003, NCI-T99-0073, OSU-99H0355, OSU-T99-0073, CDR0000067669, U01CA076576, T99-0073, NCT00005065

25.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NABTT-2116, JHOC-NABTT-2116, NCT00032097
1   
New Search